Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
management will present at the Leerink Partners Roundtable Series: Rare
Disease & Immuno-Oncology on Wednesday, September 27, 2017 at 11:30 a.m.
Management's remarks will be available live through Vertex's website at www.vrtx.com
in the "Investors" section under the "News and Events" page. A replay of
the conference webcast will be archived on the company's website.
Vertex is a global biotechnology company that aims to discover, develop
and commercialize innovative medicines so people with serious diseases
can lead better lives. In addition to our clinical development programs
focused on cystic fibrosis, Vertex has more than a dozen ongoing
research programs aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and
development sites and commercial offices in the United States, Europe,
Canada and Australia. For seven years in a row, Science magazine
has named Vertex one of its Top Employers in the life sciences. For
additional information and the latest updates from the company, please
View source version on businesswire.com: http://www.businesswire.com/news/home/20170921006078/en/
Vertex Pharmaceuticals Incorporated
Eric Rojas, 617-961-7205
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media